Previous Close | 30.32 |
1-Year Change | 66.59% |
6-Months Change | 38.01% |
3-Months Change | 51.75% |
Moving Avg (50d) | 23.412 |
Moving Avg (200d) | 22.362 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 1.45B |
Beta (3-Years) | 1.25 |
Revenue Growth (ttm) | % |
Net Profit Margin (ttm) | % |
Return On Assets (ttm) | -6.31% |
EPS (ttm) | -1.41 |
PE Ratio (ttm) | -21.5 |
Dividend Yield | % |
Asset Description: | Cassava Sciences, Inc. |
Predicted Direction: | Sell |
Signal Strength: | Neutral |
Forecast Date: | 2024-09-09 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
30.926 | 31.836 | 32.442 | 33.352 | 34.868 | 36.384 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Biotechnology |
Country: | United States |